Journal
Diabetes Technology & Therapeutics
Publication Date
10-1-2023
Volume
25
Issue
10
First Page
741
Last Page
751
Document Type
Open Access Publication
DOI
10.1089/dia.2023.0268
Rights and Permissions
Aleppo G, Hirsch IB, Parkin CG, McGill J, Galindo R, Kruger DF, Levy CJ, Forlenza GP, Umpierrez GE, Grunberger G, Bergenstal RM. Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking. Diabetes Technol Ther. 2023 Oct;25(10):741-751. doi: 10.1089/dia.2023.0268. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Recommended Citation
Aleppo, Grazia; Hirsch, Irl B; Parkin, Christopher G; McGill, Janet; Galindo, Rodolfo; Kruger, Davida F; Levy, Carol J; Forlenza, Gregory P; Umpierrez, Guillermo E; Grunberger, George; and Bergenstal, Richard M, "Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: An evidence-based approach to policymaking." Diabetes Technology & Therapeutics. 25, 10. 741 - 751. (2023).
https://digitalcommons.wustl.edu/oa_4/3627
Department
ICTS (Institute of Clinical and Translational Sciences)
